Legal Opinion

In Re Glumetza Antitrust Litigation

District Court, N.D. California

Decided May 6, 2021No. 3:19-cv-05822Unknown

1Opinion

1 2 3 4 5 6 UNITED STATES DISTRICT COURT 7 NORTHERN DISTRICT OF CALIFORNIA 8 9 10 In re No. C 19-05822 WHA 11 GLUMETZA ANTITRUST No. C 19-06138 WHA LITIGATION. No. C 19-06839 WHA 12 No. C 19-07843 WHA No. C 19-08155 WHA 13 No. C 20-01198 WHA This Document Relates to: No. C 20-05251 WHA 14 ALL ACTIONS. (Consolidated) 15 ORDER RE SUMMARY 16 JUDGMENT 17 18 INTRODUCTION 19 In a secret pharmaceutical-patent infringement settlement agreement, concealed from the 20 district judge, brand and generic manufacturers of the type 2 diabetes drug Glumetza allegedly 21 pledged not to compete with each other…

2Cases cited45 opinions

  1. United States v. Grinnell Corp.Supreme Court of the United States · 1966
  2. Zenith Radio Corp. v. Hazeltine Research, Inc.Supreme Court of the United States · 1969
  3. Zenith Radio Corp. v. Hazeltine Research, Inc.Supreme Court of the United States · 1971
  4. Brown Shoe Co. v. United StatesSupreme Court of the United States · 1962
  5. Illinois Brick Co. v. IllinoisSupreme Court of the United States · 1977

40 more not listed; retrieve them via the Exa API.

Showing a preview — retrieve the full document via the Exa API.

Powered by the Exa API